matter
earn readthrough
improv visibl theme
call despit inovalon guid remaind crl
underli demand remain strong benefit biotech
fund cite revenu alreadi cover
sign engag prompt manag guid earli
beat rise improv organ growth outlook momentum across
segment underscor strong biopharma demand fuel biotech fund
translat y/i organ growth quarter similar level
decemb quarter look ahead manag expect trend
continu make invest expand capac across geographi
china busi area limit margin expans near term
vertic integr busi model reson dsa client
buy across organ includ discoveri sa busi long
term goal time
lower improv visibl bode well lower
guidanc combin three factor time sign new contract
on-going transit legaci busi subscription-bas contract
decis longer pursu legaci contract pend busi
engag sign manag cite achiev revenu
coverag provid good visibl prompt provid
guidanc earlier expect initi guidanc call revenu
rang y/i midpoint in-lin
consensu low end in-lin prior ms estim adjust ebitda
million million versu prior ms estim million
ep versu prior ms/consensu estim
updat estim reflect lower new guidanc
chang model new vs old impli guidanc newli
issu guidanc includ exhibit exhibit
readthrough cover zack sopcak provid earli
color walgreen relationship well receiv
consum evidenc increas store traffic urgent care visit
compani remain posit exposur primari care clinic retail
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
exhibit guidanc metric
morgan stanley estim compani data
uw dcf-deriv price target includ wacc
termin growth bull/bear valuat risk price target includ
unexpect client lose continu price pressur transit pmpm price
lower expect contribut contract upsid risk includ
unannounc client win faster expect implement timelin lower
expect margin pressur
ew pt dcf deriv pt assum termin growth rate
wacc bull case valuat bear case risk research model
demand decreas faster expect develop growth fail materi
integr acquisit expans discoveri outsourc prove
challeng anticip
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report brian
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
import us regulatori disclosur subject compani
octob benefici own class common equiti secur follow compani cover morgan
stanley research athenahealth inc health corp laboratori corp america hold
within last month manag co-manag public offer offer secur inc express script inc
within last month receiv compens invest bank servic amerisourcebergen corp inc charl
next month expect receiv intend seek compens invest bank servic allscript healthcar
diplomat pharmaci inc express script inc laboratori corp america hold mckesson corpor
within last month receiv compens product servic invest bank servic
within last month provid provid invest bank servic invest bank client relationship
follow compani inc amerisourcebergen corp athenahealth inc inc
america hold mckesson corpor medidata solut inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amerisourcebergen corp
employe director consult director health corp person research analyst member research
 co llc make market secur amerisourcebergen corp
inc cerner corpor health corp diplomat pharmaci inc express script inc laboratori corp
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
